Article
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Sept 2014
Gragnani Laura, Fabbrizzi Alessio, Triboli Elisa, Urraro Teresa, Boldrini Barbara, Fognani Elisa, Piluso Alessia, Caini Patrizio, Ranieri Jessica, Monti Monica, Laffi Giacomo, Zignego Anna Linda
Abstract excerpt
BACKGROUND: Mixed cryoglobulinaemia is strongly related to hepatitis C virus infection. Treatment with peg-interferon and ribavirin has been indicated as first-line therapy for mild/moderate hepatitis C virus-related mixed cryoglobulinaemia. AIM: To evaluate the safety and efficacy of triple boceprevir-based antiviral therapy in patients with or without mixed cryoglobulinaemia previously treated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
